Toggle navigation
Home
Search
Services
Blog
Contact
About
Bioerodable Narcotic Antagonist Delivery Device
Heller, Jorge
Sri International, Menlo Park, CA, United States
Search 28 grants from Jorge Heller
Search grants from Sri International
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
A collaborative structural hub to promote Cancer Center science and drug design
Torsional stiffness and user preference: lower limb amputee lab test
Sex/Drug Tourism at the US/Mexico Border: Social Network Influences on HIV Risk.
Biogenesis of lipoarabinomannan in mycobacteria
Identification Of Mdfw: A Hearing Susceptibility Locus I
Recently added grants:
Development of Oncolytic Reovirus for Triple-Negative Breast Cancer
Elucidating the Structural Requirements for Next-Gen Glycoconjugate Vaccines
Determine the minimal level of replication required for broad protective immunity of influenza vaccine
Investigating temperature sensitive neural circuits that regulate reproductive dormancy
Identification of Ameobicidal Products Against Pathogenic Free-Living Amoebae Produced by Pseudomonas aeruginosa
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
5R01DA008561-02
Application #
2121099
Study Section
Drug Abuse Biomedical Research Review Committee (DABR)
Project Start
1993-09-30
Project End
1995-12-15
Budget Start
1994-09-01
Budget End
1995-12-15
Support Year
2
Fiscal Year
1994
Total Cost
Indirect Cost
Institution
Name
Sri International
Department
Type
DUNS #
City
Menlo Park
State
CA
Country
United States
Zip Code
94025
Related projects
NIH 1994
R01 DA
Bioerodable Narcotic Antagonist Delivery Device
Heller, Jorge / Sri International
NIH 1993
R01 DA
Bioerodable Narcotic Antagonist Delivery Device
Heller, Jorge / Sri International
Comments
Be the first to comment on Jorge Heller's grant